Zhejiang Jolly Pharmaceutical Co.,LTD

Informe acción SZSE:300181

Capitalización de mercado: CN¥11.4b

Zhejiang Jolly PharmaceuticalLTD Dirección

Dirección controles de criterios 4/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Tao Wang

Chief Executive Officer (CEO)

CN¥1.1m

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO6.8yrs
Participación del CEOn/a
Permanencia media de la dirección5.3yrs
Promedio de permanencia en la Junta Directiva4.3yrs

Actualizaciones recientes de la dirección

Recent updates

Investors Still Aren't Entirely Convinced By Zhejiang Jolly Pharmaceutical Co.,LTD's (SZSE:300181) Earnings Despite 32% Price Jump

Oct 17
Investors Still Aren't Entirely Convinced By Zhejiang Jolly Pharmaceutical Co.,LTD's (SZSE:300181) Earnings Despite 32% Price Jump

These 4 Measures Indicate That Zhejiang Jolly PharmaceuticalLTD (SZSE:300181) Is Using Debt Safely

Oct 06
These 4 Measures Indicate That Zhejiang Jolly PharmaceuticalLTD (SZSE:300181) Is Using Debt Safely

It's A Story Of Risk Vs Reward With Zhejiang Jolly Pharmaceutical Co.,LTD (SZSE:300181)

Aug 30
It's A Story Of Risk Vs Reward With Zhejiang Jolly Pharmaceutical Co.,LTD (SZSE:300181)

We Ran A Stock Scan For Earnings Growth And Zhejiang Jolly PharmaceuticalLTD (SZSE:300181) Passed With Ease

Jul 29
We Ran A Stock Scan For Earnings Growth And Zhejiang Jolly PharmaceuticalLTD (SZSE:300181) Passed With Ease

Zhejiang Jolly Pharmaceutical Co.,LTD (SZSE:300181) Held Back By Insufficient Growth Even After Shares Climb 28%

May 13
Zhejiang Jolly Pharmaceutical Co.,LTD (SZSE:300181) Held Back By Insufficient Growth Even After Shares Climb 28%

A Look At The Fair Value Of Zhejiang Jolly Pharmaceutical Co.,LTD (SZSE:300181)

May 08
A Look At The Fair Value Of Zhejiang Jolly Pharmaceutical Co.,LTD (SZSE:300181)

There's No Escaping Zhejiang Jolly Pharmaceutical Co.,LTD's (SZSE:300181) Muted Earnings

Mar 01
There's No Escaping Zhejiang Jolly Pharmaceutical Co.,LTD's (SZSE:300181) Muted Earnings

CEO

Tao Wang (56 yo)

6.8yrs

Permanencia

CN¥1,092,500

Compensación

Mr. Tao Wang serves as General Manager at Zhejiang Jolly Pharmaceutical Co., Ltd. since January 16, 2018 and has been its Non-Independent Director since May 10, 2024 and also served as its Senior Manager a...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Tao Wang
GM & Non-Independent Director6.8yrsCN¥1.09msin datos
Yuehong Shen
Deputy GM & Non-Independent Director3.8yrsCN¥743.10ksin datos
Guofu Feng
Executive Deputy GM2.6yrsCN¥807.50k0.095%
CN¥ 10.9m
Jian Chen
Deputy General Manager16.8yrsCN¥606.70k0.15%
CN¥ 17.2m
Xiao Guo Peng
Deputy General Manager6.8yrsCN¥711.50ksin datos
Xin Tan
Deputy General Manager1.8yrsCN¥721.30k0.0028%
CN¥ 315.5k

5.3yrs

Permanencia media

51.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 300181 es experimentado (5.3 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Tao Wang
GM & Non-Independent Directorless than a yearCN¥1.09msin datos
Yuehong Shen
Deputy GM & Non-Independent Director3.8yrsCN¥743.10ksin datos
Guofu Feng
Executive Deputy GM7.8yrsCN¥807.50k0.095%
CN¥ 10.9m
Youqiang Yu
Chairman21.3yrsCN¥1.03m18.92%
CN¥ 2.2b
Huifen Zhang
Non-Independent Director3.8yrsCN¥20.00ksin datos
Xuegen Zheng
Non-Independent Director16.8yrsCN¥20.00k0.11%
CN¥ 12.1m
Jian Jun Wang
Non-Independent Director7.8yrsCN¥20.00ksin datos
Bin Pan
Independent Director4.7yrsCN¥60.00ksin datos
Ping Wang
Independent Director3.8yrsCN¥60.00ksin datos
Jian Zhu
Independent Director3.8yrsCN¥60.00ksin datos
Chenghua Zhou
Chairman of the Supervisory Board6.8yrssin datossin datos
Jie Yao
Independent Directorless than a yearsin datossin datos

4.3yrs

Permanencia media

52yo

Promedio de edad

Junta con experiencia: La junta directiva de 300181 se considera experimentada (4.3 años de antigüedad promedio).